Division of Hematology, Oncology and Transplantation
-
Committed to providing the highest quality care based on cutting edge research to patients with cancer or non-malignant hematologic diseases such as sickle cell disease
-
Dedicated to advancing research on the biological underpinnings of cancer, stem cell biology, sickle cell anemia, endothelial cell biology, and tumor immunology
-
Over 50 full-time academic investigators involved in interdisciplinary research and patient care are devoted to training the next generation of academic leaders
Announcements
Zohar Sachs, MD, PhD, was the recipient of the 2019 Lois & Richard King Assistant Professorship. The Lois and Richard King Assistant Professorship in the Department of Medicine honors and recognizes the achievements of Lois and Richard King, MD. This $1 million dollar professorship was established to attract and retain an outstanding assistant professor who is doing basic science research within the Department of Medicine at the University of Minnesota. This year, the Department of Medicine received many excellent applications from qualified faculty. Dr. Sachs was selected to receive the award on the basis of her academic success in basic science research and the potential of her research program to discover cures for acute myeloid leukemia and other malignancies. Please join us in congratulating Dr. Sachs on this notable accomplishment.
June 2019
Marshall Mazepa, MD, was nominated for a prestigious 2019 Charles C. Shepard Science Award. Since 1985, the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) have presented the Shepard Science Award to authors of the most outstanding peer-reviewed research articles published by CDC/ATSDR scientists during the preceding year. As a nominated author, Dr. Mazepa will be honored for his special contribution to the mission of CDC/ATSDR and to public health. The winners in four different categories—Assessment, Prevention and Control, Laboratory Science, and Data Methods and Study Design—will be revealed at a ceremony on June 26, 2019. Dr. Mazepa was nominated for his investigations into risk factors that predict clinical bleeding severity in patients with hemophilia. Dr. Mazepa’s study results were published in an August 2018 issue of Blood Advances in an article entitled, “The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.” Please join us in congratulating Dr. Mazepa on his nomination for a Shepard Science Award.
June 2019
See more Faculty and Trainee Accomplishments